These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 9203372
41. Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines. Yang J, Xia Y, Liu X, Jiang S, Xiong L. Lasers Med Sci; 2010 Mar; 25(2):251-7. PubMed ID: 19705180 [Abstract] [Full Text] [Related]
42. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. Marti A, Lange N, van den Bergh H, Sedmera D, Jichlinski P, Kucera P. J Urol; 1999 Aug; 162(2):546-52. PubMed ID: 10411086 [Abstract] [Full Text] [Related]
43. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo. Zenzen V, Zankl H. Cancer Lett; 2003 Dec 08; 202(1):35-42. PubMed ID: 14643024 [Abstract] [Full Text] [Related]
44. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. van den Akker JT, Iani V, Star WM, Sterenborg HJ, Moan J. Photochem Photobiol; 2000 Nov 08; 72(5):681-9. PubMed ID: 11107855 [Abstract] [Full Text] [Related]
45. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. Campbell SM, Morton CA, Alyahya R, Horton S, Pye A, Curnow A. Br J Dermatol; 2008 Aug 08; 159(2):387-93. PubMed ID: 18544077 [Abstract] [Full Text] [Related]
46. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Gerscher S, Connelly JP, Griffiths J, Brown SB, MacRobert AJ, Wong G, Rhodes LE. Photochem Photobiol; 2000 Oct 08; 72(4):569-74. PubMed ID: 11045731 [Abstract] [Full Text] [Related]
47. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Forster B, Klein A, Szeimies RM, Maisch T. Exp Dermatol; 2010 Sep 08; 19(9):806-12. PubMed ID: 20636354 [Abstract] [Full Text] [Related]
48. In vivo pharmacokinetics of protoporphyrin IX accumulation following intracutaneous injection of 5-aminolevulinic acid. de Blois AW, Thissen MR, de Bruijn HS, Grouls RJ, Dutrieux RP, Robinson DJ, Neumann HA. J Photochem Photobiol B; 2001 Aug 15; 61(1-2):21-9. PubMed ID: 11485844 [Abstract] [Full Text] [Related]
49. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas. Inoue K, Karashima T, Kamada M, Shuin T, Kurabayashi A, Furihata M, Fujita H, Utsumi K, Sasaki J. Pathobiology; 2009 Aug 15; 76(6):303-14. PubMed ID: 19955842 [Abstract] [Full Text] [Related]
50. Desferrioxamine Enhances 5-Aminolaevulinic Acid- Induced Protoporphyrin IX Accumulation and Therapeutic Efficacy for Hypertrophic Scar. Chen Y, Deng H, Yang L, Guo L, Feng M. J Pharm Sci; 2023 Jun 15; 112(6):1635-1643. PubMed ID: 36682488 [Abstract] [Full Text] [Related]
51. On the role of iron and one of its chelating agents in the production of protoporphyrin IX generated by 5-aminolevulinic acid and its hexyl ester derivative tested on an epidermal equivalent of human skin. Uehlinger P, Ballini JP, van den Bergh H, Wagnières G. Photochem Photobiol; 2006 Jun 15; 82(4):1069-76. PubMed ID: 17205631 [Abstract] [Full Text] [Related]
52. Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells. Messmann H, Geisler M, Gross U, Abels C, Szeimies RM, Steinbach P, Knüchel R, Doss M, Schölmerich J, Holstege A. Br J Cancer; 1997 Jun 15; 76(7):878-83. PubMed ID: 9328146 [Abstract] [Full Text] [Related]
53. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Orenstein A, Kostenich G, Roitman L, Shechtman Y, Kopolovic Y, Ehrenberg B, Malik Z. Br J Cancer; 1996 Apr 15; 73(8):937-44. PubMed ID: 8611429 [Abstract] [Full Text] [Related]
54. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer. van den Akker JT, de Bruijn HS, Beijersbergen van Henegouwen GM, Star WM, Sterenborg HJ. Photochem Photobiol; 2000 Sep 15; 72(3):399-406. PubMed ID: 10989612 [Abstract] [Full Text] [Related]
55. Detection of early stages of carcinogenesis in adenomas of murine lung by 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Campbell DL, Gudgin-Dickson EF, Forkert PG, Pottier RH, Kennedy JC. Photochem Photobiol; 1996 Oct 15; 64(4):676-82. PubMed ID: 8863473 [Abstract] [Full Text] [Related]
56. Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells. Cosserat-Gerardin I, Bezdetnaya L, Notter D, Vigneron C, Guillemin F. J Photochem Photobiol B; 2000 Dec 15; 59(1-3):72-9. PubMed ID: 11332893 [Abstract] [Full Text] [Related]